Skip to main content
OpenTrials
Completed

NCT Number: NCT02441205

Interval Training, Inflammation and Immune Function

PURPOSE: The purpose of this study is to investigate whether High Intensity Interval Training (HIIT)can improve the health and wellbeing of pre-diabetic elderly adults. In particular, there is specific interest in describing the effects of an interval exercise program on inflammatory state and immune function.

DESIGN: Subjects will be sedentary, 65 to 80 years old adults, with prediabetes as defined by fasting plasma glucose (100 to 125 mg/dl). Before and after a 10-12 week High Intensity Interval Exercise training program subjects will undergo several tests including: 1) a maximal treadmill test, 2) an Oral Glucose Tolerance Test, 3) muscle biopsy, 4) body composition, 5) several physical function tests and 6) other health related measures including lung function, arterial stiffness and several blood measures (e.g. liver enzymes, kidney function).

DATA ANALYSES & SAFETY ISSUES: As there are no comparison groups, data analyses will consist of performing paired t-tests on pre and post exercise training values for each of the measurement variables of interest. In addition, the data will be used to provide power calculations for future grant proposals. High Intensity Interval Training is a very safe exercise modality. The regular use of vigorous intensity exercise intervals have been used extensively in exercise training. In fact, the exercise intervals will start at levels lower and will be of shorter duration than were used during the maximal exercise test. They will then be carefully and slowly made to be more challenging as each subject is able to safely tolerate.

HYPOTHESIS: The investigators hypothesize that HIIT will result in significant improvements in markers of inflammation, immune system markers and other health-related risk factors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Aging Disease Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

65 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Duke Center for Living

Durham, North Carolina, 27705, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 65-80 years
  • Prediabetic - Fasting plasma glucose is 100 - 125 on two separate days
  • Able to walk for 2 minutes or more without stopping
  • LDL Cholesterol ≤ 190; Triglycerides < 600;
  • Blood Pressure ≤ 160/90
  • Inactive: Exercise < 2 days per week
  • Medications: Stable use of all medications ≥ three months

Exclusion criteria

  • Smoker: tobacco use within the last 12 months
  • Dieting or intending to diet; not weight stable ≥ six months (weight change < 5 pounds)
  • Use of confounding inflammatory medications: aspirin, ibuprofen, naproxen (NSAIDS - nonsteriodal anti-inflammatory drugs)
  • History of diabetes, heart disease or taking medications for those conditions
  • History of hypertension (high blood pressure) not controlled with medication
  • Unwillingness to undergo muscle biopsies and all other study testing, or to continuously participate in exercise training for 12 weeks.
  • Inability to give blood continuously through a catheter (please notify the study nurse of any difficulties you have had in the past when having your blood drawn; the study nurse will determine whether you are excluded for this reason)
  • Unwillingness to conduct ALL exercise sessions at the fitness facility during research study staff supervised times.
  • Orthopedic limitations, musculoskeletal disease and/or injury Due to the nature of the study, persons with known joint, muscle or other orthopedic limitations that restrict physical activity may be excluded.
  • Able to decide if you want to take part in the study
  • Lack of transportation to the exercise and testing facilities

Treatment and study plan

High Intensity Interval Training

Behavioral

all subjects will undergo high intensity interval training 3 x per week for 10-12 weeks. the intervals of high-intensity (~85% of maximal capacity) will be 5 to 10 bouts of 30 seconds at this intensity with rest periods in between intervals that range from 30 seconds to 2 minutes

Primary outcomes

  1. Change in inflammatory markers in plasma

    Time frame: baseline and following exercise training, approximately 10-12 weeks

  2. Change in inflammatory markers in muscle

    Time frame: baseline and following exercise training, approximately 10-12 weeks

  3. Change in immune markers in peripheral blood

    Time frame: baseline and following exercise training, approximately 10-12 weeks

  4. Change in immune markers in muscle

    Time frame: baseline and following exercise training, approximately 10-12 weeks

Secondary outcomes

  1. Change in Metabolic Syndrome risk factors composite score

    Time frame: baseline and following exercise training, approximately 10-12 weeks

    Classic and additional Metabolic Syndrome measures include: blood pressure, waist circumference, triglycerides, HDL, fasting glucose; plus liver and kidney function, insulin sensitivity, glucose tolerance, etc...

Other outcomes

  1. Change in Physical Function outcome measures composite score

    Time frame: baseline and following exercise training, approximately 10-12 weeks

    Peak VO2, 400 meter walk time, short physical performance battery (SPPB)

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

The Impact of High Intensity Interval Training on Inflammatory State and Immune Function in Elderly Individuals

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
May 12, 2015
Registry last updated
Nov 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.